The Role of EGFR Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without Erlotinib
Clinical trial NCT01608841 · UNKNOWN
Trial details
- NCT number
- NCT01608841
- Sponsor
- Taipei Veterans General Hospital, Taiwan
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2015-10-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.